Skip to main content

Lynne Lederman, PhD


Authored Items
Abraxane Receives New Indication for Locally Advanced or Metastatic Non–Small-Cell Lung Cancer When Curative Surgery or Radiation Therapy Is Not an Option
Lynne Lederman, PhD
April 2013 Vol 6 No 3 Payers’ Guide to New FDA Approvals in Payers' Guide, FDA Approvals
New Directions in the Treatment of Multiple Myeloma: Reports on Carfilzomib-Based Therapy from ASH 2012
Lynne Lederman, PhD, R. Donald Harvey, PharmD, FCCP, BCOP, Beth Faiman, PhD(c), MSN, APRN-BC, AOCN, Atheer A. Kaddis, PharmD
Supplements
Ponatinib: New Option for the Treatment of Adults with CML or Ph+ ALL that Is Resistant or Intolerant to Previous Therapy with Tyrosine Kinase Inhibitors
Lynne Lederman, PhD
February 2013 Vol 6, No 1, Special Issue in FDA Approvals
Last modified: March 4, 2013